SAB Biotherapeutics, Inc. (SABS)
NASDAQ: SABS · Real-Time Price · USD
3.410
-0.010 (-0.29%)
At close: Sep 11, 2026, 4:00 PM EDT
3.500
+0.090 (2.64%)
After-hours: Sep 11, 2026, 7:30 PM EDT
SAB Biotherapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
| - | - | - | 0.11 | 0.11 | 0.38 | 1.32 | 1.51 | 2.78 | 2.6 | 2.24 | 4.09 | 6.42 | 12.68 | 23.9 | 32.8 | 43.89 | 55.75 | 60.88 | 75.57 | |
Revenue Growth (YoY) | - | - | - | -92.42% | -95.87% | -85.48% | -40.94% | -63.06% | -56.68% | -79.48% | -90.63% | -87.52% | -85.38% | -77.25% | -60.73% | -56.60% | -43.99% | -15.73% | 10.21% | - |
Cost of Revenue | 48.27 | 39.09 | 33.35 | 30.58 | 29.44 | 29.06 | 29.55 | 26.9 | 23.09 | 20.13 | 16.52 | 19.36 | 22.69 | 27.65 | 36.44 | 39.95 | 47.67 | 57.73 | 57.18 | 74.44 |
Gross Profit | -48.27 | -39.09 | -33.35 | -30.46 | -29.32 | -28.69 | -28.23 | -25.38 | -20.31 | -17.52 | -14.28 | -15.26 | -16.27 | -14.97 | -12.53 | -7.15 | -3.77 | -1.97 | 3.69 | 1.13 |
Selling, General & Admin | 23.56 | 19.09 | 15.6 | 12.73 | 12.5 | 13.61 | 14.68 | 26.39 | 25.48 | 24.54 | 23.8 | 11.8 | 13.27 | 14.64 | 16.38 | 21.26 | 20.81 | 18.94 | 17.09 | 10.02 |
Research & Development | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -11.43 |
Operating Expenses | 23.56 | 19.09 | 15.6 | 12.73 | 12.5 | 13.61 | 14.68 | 26.39 | 25.48 | 24.54 | 23.8 | 11.8 | 13.27 | 14.64 | 16.38 | 21.26 | 20.81 | 18.94 | 17.09 | -1.41 |
Operating Income | -71.82 | -58.18 | -48.95 | -43.19 | -41.82 | -42.29 | -42.91 | -51.78 | -45.79 | -42.06 | -38.08 | -27.06 | -29.55 | -29.61 | -28.92 | -28.4 | -24.58 | -20.91 | -13.39 | 2.53 |
Interest Expense | -0.23 | -0.23 | -0.24 | -0.25 | -0.28 | -0.31 | -0.32 | -0.33 | -0.32 | -0.3 | -0.32 | -0.33 | -0.33 | -0.32 | -0.3 | -0.28 | -0.29 | -0.29 | -0.29 | -0.37 |
Interest & Investment Income | 4.11 | 2.42 | 1.43 | 0.87 | 0.49 | 0.85 | 1.29 | 1.63 | 1.37 | 1.02 | 0.58 | 0.13 | 0.13 | 0.12 | 0.07 | 0.05 | 0.04 | 0.03 | 0.02 | 0.02 |
Other Non Operating Income (Expenses) | 55.17 | 55.6 | 61.04 | 61.31 | 4.56 | 7.48 | 7.84 | 4.9 | 4.41 | 1.47 | -4.39 | 0.02 | 0.53 | 2.62 | 10.38 | 6.21 | 5.43 | 3.7 | -4.15 | 0 |
EBT Excluding Unusual Items | -12.78 | -0.4 | 13.27 | 18.74 | -37.06 | -34.28 | -34.11 | -45.57 | -40.32 | -39.87 | -42.19 | -27.23 | -29.21 | -27.2 | -18.76 | -22.42 | -19.4 | -17.48 | -17.81 | 2.19 |
Gain (Loss) on Sale of Assets | - | - | - | - | - | - | - | - | - | - | - | 0.02 | 0.02 | 0.02 | 0.02 | - | - | - | - | - |
Other Unusual Items | - | - | - | - | - | - | - | - | - | - | - | 0.03 | 0.03 | 0.03 | 0.03 | - | - | - | 0.67 | 0.67 |
Pretax Income | -12.78 | -0.4 | 13.27 | 18.74 | -37.06 | -34.28 | -34.11 | -45.57 | -40.32 | -39.87 | -42.19 | -27.19 | -29.16 | -27.15 | -18.72 | -22.42 | -19.4 | -17.48 | -17.14 | 2.85 |
Income Tax Expense | - | - | - | - | - | - | - | - | - | - | - | 0.03 | 0.03 | -0.07 | 0.03 | - | - | 0.09 | - | - |
Net Income | -12.78 | -0.4 | 13.27 | 18.74 | -37.06 | -34.28 | -34.11 | -45.57 | -40.32 | -39.87 | -42.19 | -27.21 | -29.19 | -27.08 | -18.74 | -22.42 | -19.4 | -17.57 | -17.14 | 2.85 |
Preferred Dividends & Other Adjustments | 9.01 | 9.01 | 9.01 | 40.11 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -4.08 |
Net Income to Common | -21.79 | -9.41 | 4.26 | -21.37 | -37.06 | -34.28 | -34.11 | -45.57 | -40.32 | -39.87 | -42.19 | -27.21 | -29.19 | -27.08 | -18.74 | -22.42 | -19.4 | -17.57 | -17.14 | 6.93 |
Net Income Growth (YoY) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Shares Outstanding (Basic) | 48 | 30 | 19 | 10 | 9 | 9 | 9 | 9 | 8 | 7 | 6 | 5 | 5 | 5 | 4 | 4 | 4 | 3 | 3 | 2 |
Shares Outstanding (Diluted) | 48 | 30 | 61 | 10 | 9 | 9 | 9 | 9 | 8 | 7 | 6 | 5 | 5 | 5 | 4 | 4 | 4 | 3 | 3 | 2 |
Shares Change (YoY) | 417.54% | 227.56% | 562.28% | 11.65% | 21.75% | 41.12% | 67.74% | 74.13% | 61.54% | 44.93% | 26.86% | 23.46% | 31.57% | 43.39% | 59.20% | 117.46% | 72.73% | 37.02% | 1.21% | - |
EPS (Basic) | -0.45 | -0.31 | 0.22 | -2.22 | -3.99 | -3.70 | -3.68 | -5.28 | -5.29 | -6.07 | -7.64 | -5.49 | -6.18 | -5.97 | -4.31 | -5.58 | -5.41 | -5.56 | -6.27 | 3.76 |
EPS (Diluted) | -1.56 | -2.05 | -0.79 | -4.49 | -3.99 | -3.70 | -3.68 | -5.28 | -5.29 | -6.07 | -7.64 | -5.49 | -6.18 | -5.97 | -4.31 | -5.60 | -5.42 | -5.60 | -6.30 | 1.47 |
EPS Growth (YoY) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Additional Metrics
Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
Free Cash Flow | -57.44 | -53.17 | -45.71 | -37.59 | -30.93 | -31.55 | -34.63 | -38.56 | -37.42 | -34.57 | -25.32 | -13.47 | -16.22 | -16.36 | -25.63 | -31.19 | -22.63 | -27.42 | -8.96 | -2.55 |
Free Cash Flow Per Share | -1.20 | -1.75 | -0.74 | -3.90 | -3.33 | -3.40 | -3.74 | -4.47 | -4.91 | -5.26 | -4.58 | -2.72 | -3.44 | -3.61 | -5.89 | -7.77 | -6.31 | -8.67 | -3.28 | -1.38 |
Gross Margin | - | - | - | - | - | - | - | - | - | - | - | - | -253.56% | -118.02% | -52.44% | -21.79% | -8.60% | -3.54% | 6.07% | 1.49% |
Operating Margin | - | - | - | -37656.99% | -36462.89% | -11193.25% | -3244.87% | -3422.67% | -1647.04% | -1616.31% | -1700.56% | -660.87% | -460.42% | -233.50% | -120.97% | -86.59% | -56.01% | -37.51% | -22.00% | 3.35% |
Profit Margin | - | - | - | -18629.82% | -32306.67% | -9071.77% | -2579.03% | -3012.28% | -1450.33% | -1531.84% | -1884.50% | -664.53% | -454.80% | -213.53% | -78.40% | -68.34% | -44.20% | -31.51% | -28.16% | 9.17% |
Free Cash Flow Margin | - | - | - | -32770.92% | -26966.38% | -8349.52% | -2618.65% | -2548.80% | -1345.90% | -1328.30% | -1130.71% | -329.07% | -252.74% | -128.98% | -107.20% | -95.10% | -51.55% | -49.17% | -14.71% | -3.37% |
EBITDA | -68.71 | -55.12 | -45.87 | -40.09 | -38.52 | -38.71 | -38.12 | -46.82 | -40.82 | -37.26 | -34.33 | -23.24 | -25.82 | -26.03 | -25.63 | -25.51 | -22.21 | -19.03 | -11.9 | 3.56 |
EBITDA Margin | - | - | - | - | - | - | - | - | - | - | - | - | - | -205.28% | -107.20% | -77.77% | -50.59% | -34.13% | -19.55% | 4.71% |
D&A For EBITDA | 3.12 | 3.06 | 3.08 | 3.1 | 3.3 | 3.59 | 4.79 | 4.95 | 4.97 | 4.81 | 3.75 | 3.82 | 3.72 | 3.58 | 3.29 | 2.89 | 2.38 | 1.89 | 1.49 | 1.03 |
EBIT | -71.82 | -58.18 | -48.95 | -43.19 | -41.82 | -42.29 | -42.91 | -51.78 | -45.79 | -42.06 | -38.08 | -27.06 | -29.55 | -29.61 | -28.92 | -28.4 | -24.58 | -20.91 | -13.39 | 2.53 |
EBIT Margin | - | - | - | - | - | - | - | - | - | - | - | - | - | -233.50% | -120.97% | -86.59% | -56.01% | -37.51% | -22.00% | 3.35% |
Revenue as Reported | - | - | - | 0.11 | 0.11 | 0.38 | 1.32 | 1.51 | 2.78 | 2.6 | 2.24 | 4.09 | 6.42 | 12.68 | 23.9 | 32.8 | 43.89 | 55.75 | 60.88 | 75.57 |